Ukrain

From Wikiwel
Share/Save/Bookmark
Jump to: navigation, search

Ukrain is a drug based on the extract of the plant Chelidonium majus L (greater chelandine). It is claimed to be effective against a range of cancers. Greater Chelandine contains different types of alkaloids whose concentration is seasonal, similar to mistletoe, and it is approved as a medication in the Ukraine and in White Russia. It was discovered by the chemist J.W. Nowicky from Vienna, who is also the chairman of the Ukrain Institute for Cancer in Vienna
See also : Greater Celandine

Special Precautions of Ukrain

  • No serious adverse effects are on record for Ukrain but warning must be given for certain components of Ukrain. These include Chelidonium majus (greater celandine) for which reports of hepatitis exist, and thiophosphoric acid. Mild to severe adverse events such as tumour bleeding and liver toxicity have been reported.
  • Consult your doctor before using any presented information as a form of treatment. Use alternative cancer treatments as a supplement to treatments you receive from your doctor — not as a substitute for medical care. Apply the treatment only under control of an expert.

The benefits of Ukrain are

  • A greater celandine extract shows potential as an anti-cancer drug, according to a research review published in BMC Cancer in 2005. For the review, investigators analyzed seven clinical trials on the use of a proprietary greater celandine extract (called Ukrain) in treatment of cancer. Although the review's authors found that the extract had beneficial effects on several types of cancer, they caution that most of the trials were of poor quality and state that "independent rigorous studies are urgently needed" before greater celandine can be recommended in treatment of cancer.In laboratory tests on human cancer cells, scientists have found that greater celandine may fight cancer by inducing apoptosis (a type of programmed cell death involved in stopping the spread of cancer cells).
  • The data from randomised clinical trials suggest Ukrain to have potential as an anticancer drug. However, numerous caveats prevent a positive conclusion, and independent rigorous studies are urgently needed.
  • Clinical studies have shown that this highly effective derivative of a certain plant extract and thiophosphoric acid improves the overall health and strength of terminal cancer patients, boosts their immune systems and blocks tumor growth. It appears to be effective against many types of cancer, except for Leukemia and brain cancer.
  • In Germany it is primarily Dr. Burkhard Aschoff, owner of the Villa Medica Clinic in Edenkoben, in the Palatinate who has been using Ukrain for many years. He also attracted a lot of attention through two cases, when he successfully treated a 10-year old girl with an Ewing sarcoma, and in 1998 when he successfully treated a 2-year old child with a neuroblastoma using hyperthermia and Ukrain. The available data show successes with breast cancer, colon cancer and particularly with bladder cancer, and individual cases show successes for several other types of cancer. Thus 90 patients with pancreatic cancer were treated at the University of Ulm. The survival rate after 6 months with Ukrain was 65% compared to 26% for patients who were given Gemcitabine
  • Also Prof. Zemsko at the University of Kiev was able to achieve a clear extension of life for 42 patients with pancreatic cancer using a combination of Ukrain and vitamin C.
  • The results of in vitro studies also have shown the direct deletion of cancer cells and its ability to regenerate the immune system. Such a property is unusual for an anticancer agent but as it can be seen the NSC 631570 possesses some distinct immune properties.

References

Medical Disclaimer

This information is not meant to be substituted for medical advice. Always consult a medical professional regarding any medical problems and before undertaking any treatment or dietary changes.